TY - JOUR
T1 - Are there differences in perceptions, preferences and attitudes towards disclosure of genetic testing for Stroke? A qualitative study among stroke-free SIREN-SIBS genomics study participants
AU - SIREN
AU - Arulogun, Oyedunni
AU - Nichols, Michelle
AU - Jenkins, Carolyn
AU - Fakunle, Adekunle Gregory
AU - Akpa, Onoja
AU - Sarfo, Fred S.
AU - Akpalu, Albert
AU - Wahab, Kolawole
AU - Obiako, Reginald
AU - Komolafe, Morenikeji
AU - Owolabi, Lukman
AU - Osaigbovo, Godwin O.
AU - Okekunle, Akinkunmi Paul
AU - Akinyemi, Joshua
AU - Ogbole, Godwin
AU - Calys-Tagoe, Benedict
AU - Adeleye, Adeniji
AU - Mensah, Yaw
AU - Asowata, Osahon Jeffery
AU - Adeoye, Abiodun M.
AU - Appiah, Lambert
AU - Singh, Arti
AU - Adebayo, Philip
AU - Arnett, Donna
AU - Tiwari, Hemant K.
AU - Lackland, Daniel
AU - Ibinaiye, Philip
AU - Oguike, Wisdom
AU - Melikam, Chimdinma
AU - Sunday, Adeniyi
AU - Bello, Abiodun
AU - Ogah, Okechukwu
AU - Akinyemi, Rufus
AU - Ovbiagele, Bruce
AU - Owolabi, Mayowa
N1 - Publisher Copyright:
© 2023 Elsevier Inc.
PY - 2023/3
Y1 - 2023/3
N2 - Objective: This study explored perceptions, preferences and attitudes towards disclosure of genetic testing results for stroke among stroke-free controls (and their family members) in the SIREN-SIBS Genomics Study, healthcare providers and policymakers. Materials and Methods: We conducted a qualitative thematic analysis of key informant interviews with 61 participants recruited from community advisory boards (30) and health care providers (31) across seven sites in Nigeria and Ghana. Results: Major findings illustrate differences in the knowledge of genetic testing with superior knowledge among health care professionals. Relatives and religious leaders were opined as the best to receive the disclosure as they would be able to break the news to the patient in a culturally sensitive manner to reduce the likely resultant emotional outburst. Poor level of awareness of national guidelines for disclosing genetic results exist. Key facilitating factors for disclosure are education, enabling environment, involvement of religious and community leaders, campaigns, and possible treatment options. Disclosure inhibitors include inadequate information, fear of marital break-up or family displacement, fear of stigmatization, fear of isolation, religious beliefs, health worker attitude, and lack of preparedness to accept results. Conclusions: These necessitate culturally sensitive interventions for continuing education, increased awareness and sustained engagement to equip all stakeholders in genetic testing disclosure process.
AB - Objective: This study explored perceptions, preferences and attitudes towards disclosure of genetic testing results for stroke among stroke-free controls (and their family members) in the SIREN-SIBS Genomics Study, healthcare providers and policymakers. Materials and Methods: We conducted a qualitative thematic analysis of key informant interviews with 61 participants recruited from community advisory boards (30) and health care providers (31) across seven sites in Nigeria and Ghana. Results: Major findings illustrate differences in the knowledge of genetic testing with superior knowledge among health care professionals. Relatives and religious leaders were opined as the best to receive the disclosure as they would be able to break the news to the patient in a culturally sensitive manner to reduce the likely resultant emotional outburst. Poor level of awareness of national guidelines for disclosing genetic results exist. Key facilitating factors for disclosure are education, enabling environment, involvement of religious and community leaders, campaigns, and possible treatment options. Disclosure inhibitors include inadequate information, fear of marital break-up or family displacement, fear of stigmatization, fear of isolation, religious beliefs, health worker attitude, and lack of preparedness to accept results. Conclusions: These necessitate culturally sensitive interventions for continuing education, increased awareness and sustained engagement to equip all stakeholders in genetic testing disclosure process.
KW - Attitudes
KW - Genetic test disclosure
KW - Perception
KW - Preference
UR - http://www.scopus.com/inward/record.url?scp=85146092836&partnerID=8YFLogxK
U2 - 10.1016/j.jstrokecerebrovasdis.2023.106978
DO - 10.1016/j.jstrokecerebrovasdis.2023.106978
M3 - Article
AN - SCOPUS:85146092836
SN - 1052-3057
VL - 32
JO - Journal of Stroke and Cerebrovascular Diseases
JF - Journal of Stroke and Cerebrovascular Diseases
IS - 3
M1 - 106978
ER -